SCHEMBL13240992

SCHEMBL13240992

CN(C)c1cccc(CBr)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.40
CCR1 P32246 1/20 0.40
NCF1 P14598 1/20 0.39
KCNH2 Q12809 2/20 0.35
HDAC1 Q13547 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
DYRK1A Q13627 1/20 0.34
HTR1A P08908 5/20 0.34
ACACB O00763 1/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
HPGD P15428 1/20 0.33
HTR7 P34969 1/20 0.33
NOS1 P29475 1/20 0.32
NOS2 P35228 1/20 0.32
CKS1B P61024 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15341667 0.89 DYRK1A (0.40) PDE10ACCR1NCF1KCNH2HDAC1
SCHEMBL14182008 0.81 PDE10A (0.41) PDE10ANCF1KCNH2HDAC1HDAC8
SCHEMBL29549750 0.79 PDE10A (0.40) PDE10ACCR1NCF1KCNH2HDAC1
SCHEMBL30514180 0.79 PDE10A (0.43) PDE10ANCF1KCNH2HDAC1HDAC8
SCHEMBL12182706 0.79 CYP2D6 (0.42) PDE10ANCF1KCNH2HDAC1HDAC8
SCHEMBL17778301 0.79 PDE10A (0.40) PDE10ANCF1KCNH2HDAC1HDAC8
SCHEMBL1844596 0.79 PDE10A (0.43) PDE10ANCF1KCNH2HDAC1HDAC8
SCHEMBL20745285 0.79 PDE10A (0.40) PDE10ACCR1NCF1KCNH2HDAC1
SCHEMBL4073680 0.78 NPSR1 (0.35) PDE10ACCR1HTR1AKDM4EMEN1
SCHEMBL4271497 0.77 NCF1 (0.52) PDE10ANCF1DYRK1AACACBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835682-B2 Alkaloid aminoester derivatives and medicinal composition thereof CHIESI FARMACEUTICI S.P.A. (IT) 2014-09-16 US disclosed
US-20130196978-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2013-08-01 US disclosed
US-8455646-B2 Alkaloid aminoester derivatives and medicinal composition thereof CHIESI FARMACEUTICI S.P.A. (IT) 2013-06-04 US disclosed
US-20100173880-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2010-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130196978-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHRM3, CHRM1, CHRNG PDE10A 928/4885CCR1 250/4885NCF1 2563/4885
US-20100173880-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHRM3, CHRM1, CHRNG PDE10A 928/4885CCR1 250/4885NCF1 2563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.